Impact of a Review of a Smart Infusion Pump Library in Hematology/Oncology: Tailoring Content to Meet Specialty Needs.


Journal

Journal of patient safety
ISSN: 1549-8425
Titre abrégé: J Patient Saf
Pays: United States
ID NLM: 101233393

Informations de publication

Date de publication:
01 Apr 2022
Historique:
pubmed: 12 9 2021
medline: 3 5 2022
entrez: 11 9 2021
Statut: ppublish

Résumé

Errors involving chemotherapy or intravenous medications may cause serious patient harm. Dose error reduction software (DERS) for "smart" infusion pumps offers additional safety protection for their administration. Our institution uses DERS software hospital-wide; however, the hematology/oncology areas were noted to have reduced compliance with DERS recommendations. In response, we sought to review the DERS content and survey hematology/oncology end users' satisfaction with the software. A multidisciplinary working group was formed to review the current DERS entries for medications, fluids, and blood products. The review included details such as dose, rate, and concentrations. Dose error reduction software compliance was determined using vendor-supplied Continuous Quality Improvement software. An electronic survey assessing clinicians' satisfaction with the current DERS library and any challenges in its use was conducted before and after the review. Ninety-one changes were made to 71 medications by the working group. Compliance with the DERS library went from 81.5% before the review to 87.3% after the review (P = 0.257). Fifty-eight survey responses were received (30 prereview and 28 postreview) with improvements in staff satisfaction with the DERS library (83.3%-92.8%, P < 0.05). Near-miss events changed after the review from 2 to 0, and the number of alerts caused by values outside the DERS library reduced from 8788 before the review to 3383 after the review (P ≤ 0.05). Review of a hematology/oncology DERS library found improvements that better met the needs of end users. Engagement with relevant stakeholders, in conjunction with ongoing communication and review, is required to improve compliance and satisfaction with DERS.

Identifiants

pubmed: 34508039
doi: 10.1097/PTS.0000000000000907
pii: 01209203-202204000-00021
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e640-e644

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors disclose no conflict of interest.

Références

Weingart SN, Zhang L, Sweeney M, et al. Chemotherapy medication errors. Lancet Oncol . 2018;19:e191–e199.
Ranchon F, Salles G, Spath HM, et al. Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs. BMC Cancer . 2011;11:478.
Westbrook JI, Rob MI, Woods A, et al. Errors in the administration of intravenous medications in hospital and the role of correct procedures and nurse experience. BMJ Qual Saf . 2011;20:1027–1034.
Lyons I, Furniss D, Blandford A, et al. Errors and discrepancies in the administration of intravenous infusions: a mixed methods multihospital observational study. BMJ Qual Saf . 2018;27:892–901.
Schnock KO, Dykes PC, Albert J, et al. The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study. BMJ Qual Saf . 2017;26:131–140.
Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care . 2005;14:80–86.
Ohashi K, Dalleur O, Dykes PC, et al. Benefits and risks of using smart pumps to reduce medication error rates: a systematic review. Drug Saf . 2014;37:1011–1020.
Dunford BB, Perrigino M, Tucker SJ, et al. Organizational, cultural, and psychological determinants of smart infusion pump work arounds: a study of 3 U.S. Health systems. J Patient Saf . 2017;13:162–168.
Trbovich PL, Cafazzo JA, Easty AC. Implementation and optimization of smart infusion systems: are we reaping the safety benefits. J Healthc Qual . 2013;35:33–40.
Giuliano KK. Intravenous smart pumps: usability issues, intravenous medication administration error, and patient safety. Crit Care Nurs Clin North Am . 2018;30:215–224.
Guerin A, Tourel J, Delage E, et al. Accidents and incidents related to intravenous drug administration: a pre-post study following implementation of smart pumps in a teaching hospital. Drug Saf . 2015;38:729–736.
Skledar SJ, Niccolai CS, Schilling D, et al. Quality-improvement analytics for intravenous infusion pumps. Am J Health Syst Pharm . 2013;70:680–686.
Breland BD. Continuous quality improvement using intelligent infusion pump data analysis. Am J Health Syst Pharm . 2010;67:1446–1455.
Shah PK, Irizarry J, O’Neill S. Strategies for managing smart pump alarm and alert fatigue: a narrative review. Pharmacotherapy . 2018;38:842–850.
Manrique-Rodriguez S, Sanchez-Galindo A, Fernandez-Llamazares CM, et al. Smart pump alerts: all that glitters is not gold. Int J Med Inform . 2012;81:344–350.
Wiseman ML, Poole S, Ahlin A, et al. Reducing intravenous infusion errors: an observational study of 16 866 patients over five years. J Pharm Pract Res . 2018;48:49–55.
Giuliano KK, Su WT, Degnan DD, et al. Intravenous smart pump drug library compliance: a descriptive study of 44 hospitals. J Patient Saf . 2018;14:e76–e82.
Tan ISP, Dinh NT, Kong RE, et al. Audit of the use of a smart infusion pump’s drug libraries. J Pharm Pract Res . 2013;43:279–282.
McAlearney AS, Vrontos J, Schneider PJ, et al. Strategic work-arounds to accommodate new technology: the case of smart pumps in hospital care. J Patient Saf . 2007;3:75–81.
Nemeth CP, Brown J, Crandall B, et al. The mixed blessings of smart infusion devices and health care IT. Mil Med . 2014;179:4–10.
Vitoux RR, Lehr J, Chang H. Eliminating clinical workarounds through improved smart pump drug library use. Biomed Instrum Technol . 2015;49:23–28.
Rothschild JM, Keohane CA, Cook EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med . 2005;33:533–540.
Garrido M, Faus V, Lopez-Martin C, et al. GRP-175 smart infusion pumps in chemotherapy administration. Eur J Hosp Pharmcy . 2013;20:A63.1–A.
Stillman RC, Konerman E. QIM19-143: reducing risk of IV chemotherapy administration errors utilizing pump integration technology. J Natl Compr Canc Netw . 2019;17:QIM19–QI143.

Auteurs

Jeanie Misko (J)

From the Department of Pharmacy, Fiona Stanley Hospital, Perth, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH